The dysregulation of SLC13A1 and SLC6A19 are reported to affect various type of tumor progression including ccRCC (Horinouchi et al., 2010; Bogatikov et al., 2012; Choudhury et al., 2015). Here, SLC13A1 is linked to nonpapillary renal cell carcinoma.